Prediction markets move into real estate with Parcl
Polymarket has teamed up with Parcl to bring housing price indexes into prediction markets for the first time.

Finance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
Polymarket has teamed up with Parcl to bring housing price indexes into prediction markets for the first time.
Advanced Micro Devices (NASDAQ:AMD) introduced a sweeping new portfolio of x86 processors at CES 2026, targeting the burgeoning "physical AI" market.
The new Ryzen AI Embedded P100 and X100 series are designed to bring high-performance, low-latency intelligence to automotive cockpits, industrial robotics, and autonomous systems, moving complex decision-making from the cloud to the device itself.
Security-as-a-Service provider Scout Security (ASX:SCT) has signed a master services agreement and statement of work with global insurance technology company Bolt Solutions.
EQ Resources (ASX:EQR) reported a 33% increase in production for the quarter ended Dec. 31, 2025.
Australia's new vehicle market sold 1,209,808 units in 2025, highlighting the sector’s resilience amid evolving consumer preferences.
SGH and Steel Dynamics have confirmed they have submitted a non-binding indicative offer to acquire 100% of BlueScope Steel.
Mobileye Global (NASDAQ:MBLY) shares jumped more than 7% in premarket trading Monday after the company announced a massive production win with a "top-ten" U.S. automaker.
Lucid Group (NASDAQ:LCID) reported a massive surge in manufacturing activity for 2025, successfully doubling its annual production as it ramps up deliveries of its new Gravity SUV.
The California-based luxury EV maker announced Monday that it produced 18,378 vehicles for the full year, a 104% increase over 2024, narrowly beating analyst estimates of approximately 17,910 units.
HUTCHMED (NASDAQ:HCM) announced today that it has initiated the Phase III stage of its ongoing Phase II/III trial evaluating the combination of surufatinib, camrelizumab, nab-paclitaxel, and gemcitabine (S+C+AG) as a first-line treatment for patients with metastatic pancreatic ductal adenocarcinoma (PDAC) in China.
The Indian rupee slipped to a two-week low as Trump’s tariff warnings and global tensions boosted the US dollar.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy